Sakar Healthcare announced a substantial net profit increase for the first quarter of 2026-27. The company's revenue from operations also saw a significant rise during the same period. Its oncology business remains a key strategic focus for the pharmaceutical manufacturer. Sakar Healthcare executed numerous oncology product contracts and has many discussions ongoing.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZGICO6T
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Sakar Healthcare posts Rs 10-crore profit in Q1






0 comments:
Post a Comment